Gennex Laboratories informs about disclosures

24 Mar 2025 Evaluate
Gennex Laboratories has informed that the Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on March 20, 2025 for Premier Fiscal Services.

The above information is a part of company’s filings submitted to BSE.

Gennex Lab Share Price

12.30 0.16 (1.32%)
27-Mar-2025 14:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1724.65
Dr. Reddys Lab 1156.00
Cipla 1467.70
Lupin 2019.70
Zydus Lifesciences 890.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...